STERIS plc (STE)
Cash ratio
Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 171,701 | 155,178 | 172,195 | 198,328 | 207,020 | 195,585 | 213,757 | 208,614 | 208,357 | 259,371 | 258,259 | 316,327 | 348,320 | 359,089 | 383,494 | 534,774 | 220,531 | 252,502 | 312,028 | 255,627 |
Short-term investments | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Total current liabilities | US$ in thousands | 1,022,170 | 891,120 | 805,483 | 834,360 | 931,127 | 913,694 | 873,115 | 886,911 | 861,844 | 796,457 | 872,815 | 908,323 | 922,222 | 904,307 | 785,701 | 1,145,020 | 577,920 | 505,867 | 435,418 | 479,549 |
Cash ratio | 0.17 | 0.17 | 0.21 | 0.24 | 0.22 | 0.21 | 0.24 | 0.24 | 0.24 | 0.33 | 0.30 | 0.35 | 0.38 | 0.40 | 0.49 | 0.47 | 0.38 | 0.50 | 0.72 | 0.53 |
March 31, 2025 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($171,701K
+ $—K)
÷ $1,022,170K
= 0.17
The cash ratio of STERIS plc has shown a general declining trend over the analyzed period, dropping from 0.53 as of June 30, 2020, to 0.17 as of March 31, 2025. This indicates a decreasing ability of the company to cover its short-term liabilities with its available cash and cash equivalents. The ratio fluctuated within the range of 0.17 to 0.72 during this period, with notable declines in the second half of 2021 and into 2022. This may suggest potential cash flow challenges or a shift in the company's liquidity management strategies. It is important for STERIS plc to monitor its cash position and liquidity closely to ensure it can meet its financial obligations as they come due.
Peer comparison
Mar 31, 2025